Tate & Lyle | TATE - Ebit

Aktienkurs
353.20
Täglich Wechseln
-8.80 -2.43%
Monatlich
-3.87%
Jährlich
-32.21%
Q2 Prognose
341.50




Ebit Veränderung Datum
Agrana Beteiligungs EUR 20.4M 6.17M 2025-09
Anglo-eastern Plants USD 58.46M 12.31M 2025-06
Associated British Foods GBP 825M 60M 2025-12
Austevoll Seafood NOK 732M 719M 2025-12
Beiersdorf EUR 504M 312M 2025-12
British American Tobacco GBP 5B 86M 2025-12
Danone EUR 1.81B 2M 2025-06
Diageo GBP 3.26B 1.92B 2025-12
Givaudan CHF 610M 149M 2025-12
Henkel EUR 1.42B 187M 2025-12
Imperial Brands GBP 2.15B 681M 2025-12
International Flavors Fragrances USD 113M 129M 2025-12
Kerry EUR 565.6M 172M 2024-12
L'Oréal EUR 3.92B 824.8M 2025-12
Nestle CHF 6.84B 293M 2025-12
Nomad Foods EUR 100M 200K 2025-12
Ontex EUR 56.1M 8M 2025-12
Pernod Ricard EUR 967M 1.02B 2025-06
Premier Foods GBP 117.1M 300K 2025-12
Primary Health Properties ZAR 138.4M 65.8M 2025-12
Reckitt Benckiser GBP 1.79B 109M 2024-12
Tate & Lyle GBP 129M 0 2025-12
Unilever EUR 4.28B 1.53B 2025-12